Answers are grounded in this paper and cite their sources.
Noninferiority of the 4-month regimen to the standard regimen with respect to the primary efficacy end point was not shown. (Funded by the Special Program for Research and Training in Tropical Diseases and others; ClinicalTrials.gov number, NCT00216385.).
No takes yet. Share an insight, caveat, or question.
Merle et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: